Innovations will lead to better treatment, assessment for children
Data from a number of in vitro models can be combined to assess the potential for molecules to penetrate the blood-brain barrier (BBB) and cause an effect in the CNS.
An interview with Rachel Wilson, Ph.D., assistant professor of neurobiology, Harvard Medical School.
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature